Cargando…

The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples

OBJECTIVE: To explore the relationship between the viral load reflected by the Ct value of Cobas 4800 HPV test and cervical lesions, and the effectiveness of the viral load for secondary triage of HPV-positive women. METHODS: The Chinese Multi-Center Screening Trial (CHIMUST) evaluated both self-col...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Lyufang, Du, Hui, Wang, Chun, Huang, Xia, Qu, Xinfeng, Shi, Bin, Liu, Yan, Zhang, Wei, Duan, Xianzhi, Wei, Lihui, Belinson, Jerome L., Wu, Ruifang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205204/ https://www.ncbi.nlm.nih.gov/pubmed/32379782 http://dx.doi.org/10.1371/journal.pone.0232107

Ejemplares similares

A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results
por: Zhang, Yi, et al.
Publicado: (2023)

The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer
por: Duan, Lyufang, et al.
Publicado: (2020)

An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media
por: Luo, Hongxue, et al.
Publicado: (2016)

Comparison of cycle threshold values of the Cobas HPV test and viral loads of the BMRT HPV test in cervical cancer screening
por: Yang, Qing, et al.
Publicado: (2022)

Cobas 4800 HPV detection in cervical samples of Polish women
por: Smolarz, Beata, et al.
Publicado: (2019)

Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women
por: Ki, Eun Young, et al.
Publicado: (2018)

Comparison of the Cobas 4800 HPV Test and the Seeplex HPV4A ACE with the Hybrid Capture 2 Test
por: Ki, Eun Young, et al.
Publicado: (2012)

CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
por: Pesic, Aleksandra, et al.
Publicado: (2019)

Prevalence of high-risk human papillomavirus by cobas 4800 HPV test in urban Peru
por: Iwasaki, Ricardo, et al.
Publicado: (2014)

Comparative Performance of Anyplex II HPV28 and Cobas 4800 Human Papillomavirus (HPV) Assays for High-Risk HPV Detection in Self-collected Anal Samples
por: Delvallez, Gauthier, et al.
Publicado: (2023)

High-Risk Human Papillomavirus Detection via Cobas(®) 4800 and REBA HPV-ID(®) Assays
por: Liewchalermwong, Sasiprapa, et al.
Publicado: (2022)

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
por: Cook, Darrel A., et al.
Publicado: (2015)

Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening
por: Zhang, Wei, et al.
Publicado: (2020)

Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trials
por: Zhang, Yi, et al.
Publicado: (2022)

Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population
por: Liu, Stephanie S., et al.
Publicado: (2022)

Good concordance of HPV detection between cervico-vaginal self-samples and general practitioner-collected samples using the Cobas 4800 HPV DNA test
por: Tranberg, Mette, et al.
Publicado: (2018)

Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens
por: Martin, Isabella W., et al.
Publicado: (2012)

Comparison of the Cobas 4800 HPV and HPV 9G DNA Chip Tests for Detection of High-Risk Human Papillomavirus in Cervical Specimens of Women with Consecutive Positive HPV Tests But Negative Pap Smears
por: Jun, Sun-Young, et al.
Publicado: (2015)

Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples
por: Bell, Margo, et al.
Publicado: (2023)

HPV Testing by cobas HPV Test in a Population from Catalonia
por: Lloveras, Belén, et al.
Publicado: (2013)

A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening
por: Hwang, Sang-Hyun, et al.
Publicado: (2018)

Development of high-throughput genotyping method of all 18 HR HPV based on the MALDI-TOF MS platform and compared with the Roche Cobas 4800 HPV assay using clinical specimens
por: Cai, Xushan, et al.
Publicado: (2019)

Correction: HPV Testing by cobas HPV Test in a Population from Catalonia
por: Lloveras, Belén, et al.
Publicado: (2013)

Evaluation of alternately combining HPV viral load and 16/18 genotyping in secondary screening algorithms
por: Luo, Hongxue, et al.
Publicado: (2019)

HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system
por: Frayle, Helena, et al.
Publicado: (2019)

Membranous and nuclear staining of CLDN18 in HPV‐independent and HPV‐associated endocervical adenocarcinomas
por: Du, Xiuzhen, et al.
Publicado: (2022)

Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16(INK4a) immunostaining in China
por: Song, Fangbin, et al.
Publicado: (2021)

Clinical evaluation and budget impact analysis of cervical cancer screening using cobas 4800 HPV screening technology in the public sector of South Africa
por: Dreyer, Greta, et al.
Publicado: (2019)

Comparison of Alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media
por: Jang, Dan, et al.
Publicado: (2021)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Equivalent Performance of the Cobas(®) Cdiff Test for Use on the Cobas(®) Liat(®) System and the Cobas(®) 4800 System
por: Garg, Sachin K, et al.
Publicado: (2017)

An evaluation of solid versus liquid transport media for high-risk HPV detection and cervical cancer screening on self-collected specimens
por: Du, Hui, et al.
Publicado: (2020)

The Prognostic Values of HPV Genotypes and Tumor PD-L1 Expression in Patients With HPV-associated Endocervical Adenocarcinoma
por: Zhou, Feng, et al.
Publicado: (2022)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

Age-Stratified Analysis of Vaginal Microbiota Dysbiosis and the Relationship with HPV Viral Load in HPV-Positive Women
por: Li, Mingzhu, et al.
Publicado: (2022)

Endocervical Carcinogenesis and HPV Vaccination: An Occasional Circumstance or a Gap in the Chain?
por: Makris, Georgios-Marios, et al.
Publicado: (2017)

Clinicopathological features and outcomes in gastric-type of HPV-independent endocervical adenocarcinomas
por: Chen, Lili, et al.
Publicado: (2021)

Detection and Outcome of Endocervical Atypia in Cytology in Primary HPV Screening Programme
por: Pulkkinen, Johanna, et al.
Publicado: (2021)

The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples
por: Song, Fangbin, et al.
Publicado: (2020)

The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening
por: Aitken, Clare A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bdqtkodilrm80r8llfem906qvo